Oluyemi Okupe Sells 11,581 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 11,581 shares of the company's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $43.01, for a total value of $498,098.81. Following the completion of the sale, the chief financial officer now owns 107,789 shares of the company's stock, valued at approximately $4,636,004.89. This trade represents a 9.70 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Oluyemi Okupe also recently made the following trade(s):

• On Tuesday, February 4th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $38.92, for a total transaction of $450,732.52.
• On Monday, January 13th, Oluyemi Okupe sold 11,581 shares of Hims & Hers Health stock. The stock was sold at an average price of $24.44, for a total transaction of $283,039.64.
• On Thursday, December 26th, Oluyemi Okupe sold 4,213 shares of Hims & Hers Health stock. The shares were sold at an average price of $29.98, for a total value of $126,305.74.
• On Friday, December 20th, Oluyemi Okupe sold 18,959 shares of Hims & Hers Health stock. The shares were sold at an average price of $25.77, for a total value of $488,573.43.
• On Monday, November 25th, Oluyemi Okupe sold 101,993 shares of Hims & Hers Health stock. The stock was sold at an average price of $29.62, for a total transaction of $3,021,032.66.
• On Wednesday, November 13th, Oluyemi Okupe sold 142,886 shares of Hims & Hers Health stock. The stock was sold at an average price of $29.93, for a total transaction of $4,276,577.98.

Hims & Hers Health Stock Performance

Shares of HIMS traded up $1.23 during trading hours on Friday, hitting $60.41. 38,691,338 shares of the company were exchanged, compared to its average volume of 11,475,684. The company has a market cap of $13.20 billion, a PE ratio of 137.31 and a beta of 1.35. The firm's 50 day moving average is $32.06 and its 200-day moving average is $24.28. Hims & Hers Health, Inc. has a 52 week low of $9.22 and a 52 week high of $64.84.

Analyst Ratings Changes

Several analysts have issued reports on HIMS shares. TD Cowen reissued a "buy" rating and set a $28.00 target price on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Bank of America downgraded Hims & Hers Health from a "buy" rating to an "underperform" rating and reduced their price objective for the stock from $32.00 to $18.00 in a research note on Thursday, November 14th. Citigroup downgraded Hims & Hers Health from a "neutral" rating to a "sell" rating and increased their price objective for the stock from $24.00 to $25.00 in a research note on Friday, January 10th. Morgan Stanley began coverage on shares of Hims & Hers Health in a report on Tuesday, December 17th. They set an "overweight" rating and a $42.00 price target for the company. Finally, BTIG Research initiated coverage on shares of Hims & Hers Health in a report on Tuesday, January 7th. They set a "buy" rating and a $35.00 price target for the company. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $25.13.

Hedge Funds Weigh In On Hims & Hers Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Main Management ETF Advisors LLC acquired a new position in Hims & Hers Health during the third quarter valued at approximately $672,000. Robeco Institutional Asset Management B.V. bought a new position in Hims & Hers Health in the 3rd quarter worth $604,000. Carnegie Investment Counsel acquired a new position in shares of Hims & Hers Health during the 3rd quarter worth about $5,531,000. Royce & Associates LP lifted its position in shares of Hims & Hers Health by 17.0% during the 3rd quarter. Royce & Associates LP now owns 341,000 shares of the company's stock worth $6,281,000 after purchasing an additional 49,500 shares during the last quarter. Finally, Versor Investments LP acquired a new position in shares of Hims & Hers Health during the 3rd quarter worth about $634,000. Institutional investors and hedge funds own 63.52% of the company's stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.